Fuchs Dystrophy News Today

/PRNewswire/ -- DelveInsights Corneal Implant Market Insights report provides the current and forecast market analysis, individual leading corneal implant...

Jan 2, 2024: α-MSH aids corneal healing, restores function, protects against cell death, promotes regeneration - The Am. J. of Pathology.

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.

Administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The

One reader calls for compassion in the debate about assisted dying, while others consider issues including public spending, organ donation, hunting, and landlords rights 

Fuchs' dystrophy is a disease affecting your cornea. Learn about Fuchs' dystrophy, including its causes, symptoms, and treatments.

/PRNewswire/ -- The "Corneal Implants Market Size, Share & Trends Analysis Report by Type (Human Cornea, Synthetic), by Application (Keratoconus, Fuchs...

Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Corneal Implants Market Size, Share & Trends Analysis Report by Type (Human Cornea, Synthetic), by...

/PRNewswire/ -- DelveInsights Fuchs Endothelial Corneal Dystrophy Market Insights report includes a comprehensive understanding of current treatment...